“Deucravacitinib in Moderate Plaque Psoriasis: Efficacy in the Phase 3 POETYK PSO-1 and PSO-2 Trials ”. 2024. SKIN The Journal of Cutaneous Medicine 8 (2): s364. https://doi.org/10.25251/skin.8.supp.364.